OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe
Samuel Seidu, Xavier Cos, Stephen Brunton, et al.
Primary care diabetes (2020) Vol. 15, Iss. 1, pp. 31-51
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 686

Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ramzi Ajjan, Tadej Battelino, Xavier Cos, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 7, pp. 426-440
Closed Access | Times Cited: 22

GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis
Thomas Karagiannis, Απόστολος Τσάπας, Eleni Athanasiadou, et al.
Diabetes Research and Clinical Practice (2021) Vol. 174, pp. 108737-108737
Closed Access | Times Cited: 97

Simple, Skin-Attachable, and Multifunctional Colorimetric Sweat Sensor
Xiaoping Yue, Feiyang Xu, Linrong Zhang, et al.
ACS Sensors (2022) Vol. 7, Iss. 8, pp. 2198-2208
Closed Access | Times Cited: 59

Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study
Neda Rajamand Ekberg, Ulrik Bodholdt, Andrei‐Mircea Catarig, et al.
Primary care diabetes (2021) Vol. 15, Iss. 5, pp. 871-878
Open Access | Times Cited: 46

A Meta-Analysis of the Effectiveness of Telemedicine in Glycemic Management among Patients with Type 2 Diabetes in Primary Care
Anqi Zhang, Jinsong Wang, Xiaojuan Wan, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 7, pp. 4173-4173
Open Access | Times Cited: 29

Sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice
Kamlesh Khunti, Serge Jabbour, Xavier Cos, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 7, pp. 1187-1196
Open Access | Times Cited: 26

Evaluation of clinical and antidiabetic treatment characteristics of different sub-groups of patients with type 2 diabetes: Data from a Mediterranean population database
Manel Mata‐Cases, Josep Franch‐Nadal, Jordi Real, et al.
Primary care diabetes (2021) Vol. 15, Iss. 3, pp. 588-595
Open Access | Times Cited: 32

Adherence to antidiabetic treatment among patients managed in primary care centres in Spain: the INTENSE study
Bogdan Vlacho, F. López Simarro, Manel Mata‐Cases, et al.
Primary care diabetes (2022) Vol. 16, Iss. 6, pp. 760-767
Closed Access | Times Cited: 20

Technology in the Management of Type 1 and Type 2 Diabetes Mellitus: Recent Status and Future Prospects
Titas Biswas, Biplab Kumar Behera, Nithar Ranjan Madhu
(2023), pp. 111-136
Closed Access | Times Cited: 12

Control of Glucose, Blood Pressure, and Cholesterol among Adults with Diabetes: The Brazilian National Health Survey
Rodrigo Citton Padilha dos Reis, Bruce Bartholow Duncan, Célia Landmann Szwarcwald, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 15, pp. 3428-3428
Open Access | Times Cited: 21

Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2022
Domingo Orozco‐Beltrán, Carlos Brotons Cuixart, José R. Banegas, et al.
Atención Primaria (2022) Vol. 54, pp. 102444-102444
Open Access | Times Cited: 12

Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020
Domingo Orozco‐Beltrán, Carlos Brotons Cuixart, José Juan Alemán Sánchez, et al.
Atención Primaria (2020) Vol. 52, pp. 5-31
Open Access | Times Cited: 17

Enhance the oral insulin delivery route using a modified chitosan-based formulation fabricated by microwave
Huda Salem AlSalem, Nisreen M. Abdulsalam, Najla A. Khateeb, et al.
International Journal of Biological Macromolecules (2023) Vol. 247, pp. 125779-125779
Closed Access | Times Cited: 6

Temporal trends in co‐morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK
Joanna Ling, Digsu N. Koye, Luke Buizen, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 5, pp. 1150-1161
Closed Access | Times Cited: 14

Opportunities and risks within the expanding role of general practice
Elizabeth M Speakman, Helen Jarvis, David Whiteley
British Journal of General Practice (2021) Vol. 71, Iss. 709, pp. 344-345
Open Access | Times Cited: 13

Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review
Kevin Fernando, Stephen C. Bain, Patrick Holmes, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 9, pp. 2267-2288
Open Access | Times Cited: 11

Will oral semaglutide be a game-changer in the management of type 2 diabetes in primary care?
Samuel Seidu, Linda Mellbin, Marcel Kaiser, et al.
Primary care diabetes (2020) Vol. 15, Iss. 1, pp. 59-68
Open Access | Times Cited: 11

Report from the CVOT Summit 2020: new cardiovascular and renal outcomes
Oliver Schnell, Xavier Cos, Francesco Cosentino, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 10

Prevention of Cardiorenal Complications with Sodium–Glucose Cotransporter Type 2 Inhibitors: A Narrative Review
Manuel Botana, Javier Escalada, Ángel Merchante, et al.
Diabetes Therapy (2022) Vol. 13, Iss. S1, pp. 5-17
Open Access | Times Cited: 6

Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study
Bogdan Vlacho, Manel Mata‐Cases, Xavier Mundet, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 7

Potential Risk of Overtreatment in Patients with Type 2 Diabetes Aged 75 Years or Older: Data from a Population Database in Catalonia, Spain
Manel Mata‐Cases, Dı́dac Mauricio, Jordi Real, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5134-5134
Open Access | Times Cited: 4

Impact on guidelines: The general practitioner point of view
Xavier Cos, Samuel Seidu, Stephen Brunton, et al.
Diabetes Research and Clinical Practice (2020) Vol. 166, pp. 108091-108091
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top